A detailed history of Northcape Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Northcape Wealth Management, LLC holds 6,077 shares of BMY stock, worth $351,007. This represents 0.1% of its overall portfolio holdings.

Number of Shares
6,077
Previous 6,726 9.65%
Holding current value
$351,007
Previous $279,000 12.54%
% of portfolio
0.1%
Previous 0.1%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$39.66 - $51.75 $25,739 - $33,585
-649 Reduced 9.65%
6,077 $314,000
Q2 2024

Jul 25, 2024

BUY
$40.25 - $52.99 $10,223 - $13,459
254 Added 3.92%
6,726 $279,000
Q1 2024

Apr 30, 2024

SELL
$47.98 - $54.4 $10,171 - $11,532
-212 Reduced 3.17%
6,472 $350,000
Q4 2023

Feb 05, 2024

BUY
$48.48 - $57.85 $19,488 - $23,255
402 Added 6.4%
6,684 $342,000
Q3 2023

Nov 06, 2023

BUY
$57.89 - $64.73 $176,275 - $197,102
3,045 Added 94.07%
6,282 $364,000
Q2 2023

Aug 07, 2023

BUY
$63.71 - $70.74 $14,016 - $15,562
220 Added 7.29%
3,237 $207,000
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $198,247 - $224,857
3,017 New
3,017 $209,000
Q3 2022

Nov 08, 2022

BUY
$0.13 - $76.84 $305 - $180,574
2,350 Added 73.05%
5,567 $396,000
Q2 2022

Aug 09, 2022

SELL
$72.62 - $79.98 $151,049 - $166,358
-2,080 Reduced 39.27%
3,217 $248,000
Q1 2022

Apr 18, 2022

BUY
$61.48 - $73.72 $127,878 - $153,337
2,080 Added 64.66%
5,297 $387,000
Q4 2021

Feb 09, 2022

BUY
$53.63 - $62.52 $172,527 - $201,126
3,217 New
3,217 $201,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Northcape Wealth Management, LLC Portfolio

Follow Northcape Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northcape Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northcape Wealth Management, LLC with notifications on news.